ISLAMABAD – Thousands of Pakistani migrant labourers fear that they might lose their jobs after the governments of Saudi Arabia and the United Arab Emirates (UAE) banned entry for Pakistanis vaccinated with COVID-19 vaccines produced in China. Meanwhile, Europe’s digital ‘Green Pass’ is not available to those vaccinated by the AstraZeneca vaccine made by the […] Continue reading ->
Healthcare professionals, and particularly community health workers who have been the backbone of local and national health systems during the COVID crisis, are also unsung ‘first responders’ to the massive mental health fallout from the pandemic, now and going forward.   That is the central theme of a webinar panel on ‘COVID-19 and Frontline Workers’, Wednesday, 30th […] Continue reading ->
Africa could start producing its own cutting-edge COVID-19 vaccines within a year via an mRNA technology transfer hub that is being set up in South Africa, the World Health Organization (WHO) announced on Monday. But the speed at which the new hub may be able to swing into full-scale vaccine production depends on whether pharmaceutical […] Continue reading ->
Proponents of a sweeping World Trade Organization ‘waiver’ on intellectual property rights for all COVID-19 treatments, tests and vaccines face an uphill battle to reach consensus on a text ahead of a WTO General Council meeting scheduled for 27-28 July.  This is despite the recent agreement of the initiative’s opponents, including the European Union, Korea, […] Continue reading ->
From Indonesia and the Seychelles, to Chile and China itself, there are some worrisome indications that the Chinese Sinopharm and Sinovac COVID vaccines sold by the hundreds of millions to vaccine-strapped low- and middle-income countries may not be performing as well as expected – particularly against rapidly spreading variants of SARS-CoV-2.   At the same time, […] Continue reading ->
A COVID-19 antibody cocktail developed by the US-based company, Regeneron, dramatically reduced the risk of mortality and shortened hospital stays in patients who didn’t naturally produce antibodies against SARS-CoV2 in a recent large-scale trial.  Meanwhile, the US government announced that it would invest some US$3.2 billion in developing new forms of antiviral COVID-19 treatments to […] Continue reading ->